Sitting still for seven or eight hours on a long-haul flight raises real questions about deep vein thrombosis (DVT), and some travelers have started asking whether nattokinase can help. The interest is not baseless. A specific nattokinase-containing formula has actually been tested in a randomized, placebo-controlled flight trial, which puts this question on firmer ground than most nattokinase claims.
Key Takeaways
- The LONFLIT-FLITE trial tested a combination of nattokinase (150 mg) and pycnogenol on 204 passengers on a long New York to London flight, with zero DVT cases in the treated group scanned by ultrasound afterward.
- That trial tested a specific branded combination product, not plain nattokinase alone taken casually, so the results don’t automatically generalize to any nattokinase supplement.
- Baseline DVT risk from long-haul flying is already low for most healthy travelers, roughly 1 event per 4,656 long-haul flights in a large cohort study.
- Nattokinase’s anticoagulant effect means it should not be combined with in-flight alcohol, NSAIDs, or existing blood thinners without medical advice.
- Compression stockings, hydration, and calf exercises remain the best-evidenced, lowest-risk DVT prevention strategies regardless of supplement use.
This post contains affiliate links. As an Amazon Associate, NattokinaseHub earns from qualifying purchases at no extra cost to you.
The Trial Behind the Claim
The most cited research here is the LONFLIT-FLITE randomized controlled trial, published in Angiology in 2003. Researchers enrolled 204 higher-risk passengers on a long-haul flight and randomized them to an active supplement or placebo, alongside standard advice like isometric leg exercises and hydration. The active group took a formula combining nattokinase (roughly 150 mg per dose) with pycnogenol, a pine bark extract with its own vascular research base, dosed once about two hours before departure and again roughly six hours into the flight.
Ultrasound scans of the femoral, popliteal, tibial, and superficial veins were performed before departure and again within 90 minutes of landing. According to reporting on the trial, the group receiving the active formula had zero cases of DVT detected, while thrombotic events occurred in the placebo group. That is a meaningful result, but it describes one trial from one research group testing a specific two-ingredient combination product, not nattokinase in isolation.
How Nattokinase Fits the Mechanism
Nattokinase is a fibrinolytic enzyme, meaning it can help break down fibrin, the structural protein that forms the mesh of a blood clot, and reduce levels of fibrinogen, its precursor. Long-haul flights create DVT risk through a combination of prolonged immobility, cabin pressure changes, and mild dehydration, all of which can slow venous blood flow in the legs and increase clotting tendency. A fibrinolytic and mildly anticoagulant supplement is a biologically plausible add-on to standard prevention measures, which is why researchers tested it in the first place.
Who Is Actually at Elevated Risk
Context matters before reaching for any supplement. A large cohort study of 8,755 international organization employees found the incidence of venous thrombosis linked to long-haul flights was 3.2 per 1,000 person-years, compared with 1.0 per 1,000 for non-flying periods, working out to roughly one clot event per 4,656 long-haul flights. For most healthy adults without additional risk factors, that baseline risk is low. People at meaningfully elevated risk include those with a personal or family history of DVT or pulmonary embolism, recent surgery, active cancer, pregnancy, obesity, or known clotting disorders, and this group should talk to a physician about flight-specific prevention rather than self-treating with a supplement.
What This Means for Casual Nattokinase Use Before a Flight
If you already take nattokinase regularly under medical guidance, there is no specific reason to stop before a flight, assuming your prescriber has already weighed the bleeding risk. But starting nattokinase specifically and only for a single flight, without a doctor’s input, is a different decision than what the LONFLIT-FLITE trial actually tested, and it introduces bleeding-risk considerations, particularly if combined with alcohol, NSAIDs like ibuprofen, or an existing anticoagulant.
Evidence-Backed Basics Still Come First
Regardless of supplement choice, the interventions with the deepest evidence base for flight-related DVT prevention are graduated compression stockings, staying hydrated, avoiding excess alcohol, and moving your legs and ankles periodically during the flight. These carry essentially no bleeding risk and are appropriate for nearly everyone, which makes them a more sensible starting point than adding an anticoagulant supplement purely for a single trip.
Frequently Asked Questions
Does nattokinase actually prevent DVT on flights?
One randomized controlled trial found zero DVT cases in passengers who took a specific nattokinase-pycnogenol combination before and during a long flight, compared with cases in the placebo group. That is a real and interesting result, but it comes from a single research group testing one branded formula, not general proof that any nattokinase supplement will do the same.
Is it safe to start nattokinase just for a single flight?
Talk to your doctor first, especially if you take other medications or have any bleeding risk factors. Nattokinase affects clotting, and starting it casually, without medical guidance, right before travel is not the same as the supervised trial protocol.
Who is actually at high risk for flight-related DVT?
People with a personal or family history of clots, recent surgery, active cancer, pregnancy, obesity, or known clotting disorders face meaningfully higher risk than average healthy travelers and should discuss prevention specifically with a physician.
What prevents flight DVT with the strongest evidence?
Compression stockings, staying hydrated, limiting alcohol, and periodic leg movement have the most consistent supporting evidence and carry essentially no bleeding risk, making them the sensible first line for nearly all travelers.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always talk to your doctor before starting nattokinase, especially if you take blood thinners or have an upcoming surgery.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
